418 related articles for article (PubMed ID: 29580037)
21. Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation.
Bisio F; Bozzano F; Marras F; Di Biagio A; Moretta L; De Maria A
Immunol Lett; 2013 Apr; 152(1):16-24. PubMed ID: 23538009
[TBL] [Abstract][Full Text] [Related]
22. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
23. NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.
Dulphy N; Berrou J; Campillo JA; Bagot M; Bensussan A; Toubert A
J Invest Dermatol; 2009 Feb; 129(2):359-64. PubMed ID: 18754036
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.
Zou Y; Song ZX; Lu Y; Liang XL; Yuan Q; Liao SH; Bao JJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):509-513. PubMed ID: 27465324
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
26. Changes in natural killer cell subsets in pediatric liver transplant recipients.
Pham B; Piard-Ruster K; Silva R; Gallo A; Esquivel CO; Martinez OM; Krams SM
Pediatr Transplant; 2012 Mar; 16(2):176-82. PubMed ID: 22360401
[TBL] [Abstract][Full Text] [Related]
27. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
[TBL] [Abstract][Full Text] [Related]
29. Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection.
Das R; Tripathy A
Med Microbiol Immunol; 2014 Oct; 203(5):303-14. PubMed ID: 24824867
[TBL] [Abstract][Full Text] [Related]
30. [Expression and significance of the NK cell receptors in primary hepatocellular carcinoma and paracancerous tissues].
Jiang JH; Zhou ZF; Li JY; Ye YB; Chen Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):529-32. PubMed ID: 22558993
[TBL] [Abstract][Full Text] [Related]
31. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T
PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628
[TBL] [Abstract][Full Text] [Related]
32. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
33. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
[TBL] [Abstract][Full Text] [Related]
34. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
[TBL] [Abstract][Full Text] [Related]
35. IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.
Schilling B; Halstead ES; Schuler P; Harasymczuk M; Egan JE; Whiteside TL
Cancer Immunol Immunother; 2012 Sep; 61(9):1395-405. PubMed ID: 22270713
[TBL] [Abstract][Full Text] [Related]
36. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
Alter G; Jost S; Rihn S; Reyor LL; Nolan BE; Ghebremichael M; Bosch R; Altfeld M; Lauer GM
J Hepatol; 2011 Aug; 55(2):278-88. PubMed ID: 21168454
[TBL] [Abstract][Full Text] [Related]
37. Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2D
Bonacini M; Cimino L; De Simone L; Bolletta E; Gozzi F; Soriano A; Muratore F; Zerbini A; Fontana L; Salvarani C; Croci S
Clin Exp Immunol; 2021 Apr; 204(1):41-48. PubMed ID: 33314028
[TBL] [Abstract][Full Text] [Related]
38. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
39. Expression of NK cell and monocyte receptors in critically ill patients--potential biomarkers of sepsis.
Kjaergaard AG; Nielsen JS; Tønnesen E; Krog J
Scand J Immunol; 2015 Apr; 81(4):249-58. PubMed ID: 25619264
[TBL] [Abstract][Full Text] [Related]
40. NK cells suppress CD8
Chen T; Zhang T; Liu C; Wang C; Ding S; Shao Z; Fu R
Cell Immunol; 2019 Jan; 335():6-14. PubMed ID: 30471872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
